Skip to content

BIO-TECHNE Corp

TECH

CIK 0000842023

Revenue (TTM)
$1.21B
+5.2% YoY Q3 Apr 2026
Net Income (TTM)
$149.83M
−56.3% YoY Q3 Apr 2026
EPS Diluted (TTM)
$0.94
−56.2% YoY Q3 Apr 2026
Gross Margin
66.3%
Q3 Apr 2026
Operating Margin
17.9%
Q3 Apr 2026
Net Margin
12.4%
Q3 Apr 2026
Free Cash Flow (TTM)
$169.26M
Q3 Apr 2026
Cash
$209.82M
Q3 Apr 2026
Total Debt
$12.5M
Q3 Apr 2026
Shares Outstanding
156.57M sh
Q3 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings